Use of r-DNA Technology in Manufacturing of Diabetes Insulin amounts to A Mono Component Insulin: CESTAT allows Customs Duty Exemption
The Customs, Excise, and Service Tax Appellate Tribunal CESTAT allowed a customs duty exemption for the use of recombinant DNA r-DNA technology in the manufacturing of insulin for…